Bicitra and Dupilumab Subcutaneous
Determining the interaction of Bicitra and Dupilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: citric acid / sodium citrate
Brand name: Bicitra, Cytra-2, Liqui-Dual Citra, Oracit, Shohl's Solution, Virtrate-2
Synonyms: n.a.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bicitra-Dupixent
- Bicitra-Duplex T Topical
- Bicitra-Durachol
- Bicitra-Duraclon
- Bicitra-Duraclon injection
- Bicitra-Duraflu
- Dupilumab Subcutaneous-BiCNU
- Dupilumab Subcutaneous-Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamide Fumarate
- Dupilumab Subcutaneous-Bictegravir, emtricitabine, and tenofovir
- Dupilumab Subcutaneous-Bictegravir, Emtricitabine, and Tenofovir Alafenamide
- Dupilumab Subcutaneous-Bidex-A
- Dupilumab Subcutaneous-BiDil